<p>Health Catalyst, Inc.（纳斯达克代码：HCAT - 获取免费报告）董事 Julie Larson-Green 于 12 月 4 日星期四出售了 47,997 股公司的股票。该股票以平均价格 2.67 美元出售，总价值为 128,151.99 美元。交易完成后，该董事在公司持有 73,573 股，价值 196,439.91 美元。这代表其持股比例减少了 39.48%。该交易已在与证券交易委员会的法律文件中披露，您可以通过此链接访问。</p>
<p>获取 <strong>Health Catalyst</strong> 的提醒：</p>
<h2>Health Catalyst 股价下跌 1.1%</h2>
<ul>
<li>健康科技复苏：3 只股票有望在 2025 年大幅反弹</li>
</ul>
<p>在周二的交易中，纳斯达克 HCAT 股价下跌 0.03 美元，达到 2.61 美元。493,261 股股票易手，交易量低于其平均交易量 704,965 股。Health Catalyst, Inc.的 52 周最低价为 2.02 美元，52 周最高价为 8.52 美元。该公司的速动比率为 1.88，流动比率为 1.88，债务与股本比率为 0.46。该公司的市值为 1.8461 亿美元，市盈率为-1.64，贝塔值为 1.72。该股票的 50 日移动平均价格为 2.83 美元，200 日移动平均价格为 3.30 美元。</p>
<p>Health Catalyst（纳斯达克代码：HCAT - 获取免费报告）最近在 11 月 10 日星期一发布了季度财报。该公司报告本季度每股收益为 0.06 美元，超出市场共识预期的 0.05 美元，超出 0.01 美元。Health Catalyst 的股本回报率为-6.67%，净利润率为-34.05%。该公司本季度的收入为 7632 万美元，超过市场共识预期的 7505 万美元。分析师预测 Health Catalyst, Inc.本年度将发布-0.33 美元的每股收益。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>2021 年 6 月华尔街分析师推荐的 10 只顶级股票</li>
</ul>
<p>HCAT 已成为多份研究报告的主题。Piper Sandler 在 8 月 27 日星期三的研究报告中将 Health Catalyst 的评级从 “超配” 下调至 “中性”，并将其目标价从 8.00 美元下调至 4.00 美元。瑞银集团在 11 月 11 日星期二的报告中重申了对 Health Catalyst 股票的 “跑赢大盘” 评级。花旗集团在 11 月 11 日星期二的研究报告中将 Health Catalyst 股票的目标价从 3.50 美元下调至 3.25 美元，并对该公司设定了 “中性” 评级。Evercore ISI 在 10 月 8 日星期三的报告中将 Health Catalyst 股票的目标价从 4.00 美元下调至 3.00 美元，并对该股票设定了 “持平” 评级。最后，加拿大皇家银行在 8 月 29 日星期五的研究报告中将 Health Catalyst 股票的目标价从 9.00 美元下调至 5.00 美元，并对该公司设定了 “买入” 评级。五家股票研究分析师对该股票给予了买入评级，八家给予了持有评级，一家给予了卖出评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价为 4.36 美元。</p>
<p><strong>获取我们对 Health Catalyst 的最新分析</strong></p>
<h2>机构资金流入和流出</h2>
<p>最近，一些对冲基金买入和卖出了 HCAT 的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Health Catalyst 的股份增加了 7.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前拥有 36,047 股公司股票，价值 163,000 美元，此前在上个季度购买了 2,624 股。Campbell &amp; CO Investment Adviser LLC 在第二季度将其在 Health Catalyst 的股份增加了 9.7%。Campbell &amp; CO Investment Adviser LLC 目前拥有 43,051 股公司股票，价值 162,000 美元，此前在上个季度购买了 3,808 股。制造商人寿保险公司在第二季度将其在 Health Catalyst 的持股增加了 19.6%。制造商人寿保险公司目前拥有 26,491 股公司股票，价值 100,000 美元，此前在上个季度购买了 4,341 股。法国巴黎银行金融市场在第三季度将其在 Health Catalyst 的持股增加了 71.7%。法国巴黎银行金融市场目前拥有 16,355 股公司股票，价值 47,000 美元，此前在上个季度购买了 6,832 股。最后，Probity Advisors Inc.在第三季度将其在 Health Catalyst 的持股增加了 20.5%。Probity Advisors Inc.目前拥有 45,161 股公司股票，价值 129,000 美元，此前在上个季度购买了 7,671 股。85.00% 的股票目前由机构投资者持有。</p>
<h2>关于 Health Catalyst</h2>
<p>（获取免费报告）</p>
<p>Health Catalyst, Inc.为美国的医疗组织提供数据和分析技术及服务。它分为两个部门，技术和专业服务。该公司提供数据操作系统数据平台，为客户提供一个综合环境，以整合和组织来自不同软件系统的数据；以及分析应用程序，这是为数据平台构建的软件分析应用程序，用于分析客户在临床和质量、人口健康以及财务和运营用例方面面临的问题。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Health Catalyst 更好</li>
<li>什么是股票市场指数，如何使用它们？</li>
<li>消费者得到了煤炭，但圣诞老人给这两家零售商带来了巨大的收益</li>
<li>银行股票 - 最佳银行股票投资指南</li>
<li>10 倍收益？这三只机器人股票可能在 2035 年爆发</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>安海斯 - 布希收购 BeatBox 以吸引年轻饮酒者</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Health Catalyst 吗？</h2>
<p>在考虑 Health Catalyst 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前购买……而 Health Catalyst 并不在名单上。</p>
<p>虽然 Health Catalyst 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCAT

<p>Health Catalyst 董事 Julie Larson-Green 出售了 47,997 股，交易金额为 128,151.99 美元，减持幅度为 39.48%。此次出售在 SEC 文件中披露。Health Catalyst 的股票下跌 1.1%，报 2.61 美元，市值为 1.8461 亿美元。分析师的评级不一，平均目标价为 4.36 美元。机构投资者已调整在该公司的持股</p>

<p>Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) Director Julie Larson-Green sold 47,997 shares of the firm's stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $2.67, for a total value of $128,151.99. Following the completion of the transaction, the director owned 73,573 shares in the company, valued at $196,439.91. This represents a 39.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink.</p>
<div class="lb-trans"><p>Health Catalyst, Inc.（纳斯达克代码：HCAT - 获取免费报告）董事 Julie Larson-Green 于 12 月 4 日星期四出售了 47,997 股公司的股票。该股票以平均价格 2.67 美元出售，总价值为 128,151.99 美元。交易完成后，该董事在公司持有 73,573 股，价值 196,439.91 美元。这代表其持股比例减少了 39.48%。该交易已在与证券交易委员会的法律文件中披露，您可以通过此链接访问。</p>
</div><p>Get <strong>Health Catalyst</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Health Catalyst</strong> 的提醒：</p>
</div><h2>Health Catalyst Trading Down 1.1%</h2>
<div class="lb-trans"><h2>Health Catalyst 股价下跌 1.1%</h2>
</div><ul>
<li>Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>健康科技复苏：3 只股票有望在 2025 年大幅反弹</li>
</ul>
</div><p>NASDAQ HCAT traded down $0.03 during trading on Tuesday, reaching $2.61. 493,261 shares of the stock traded hands, compared to its average volume of 704,965. Health Catalyst, Inc. has a fifty-two week low of $2.02 and a fifty-two week high of $8.52. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.46. The firm has a market cap of $184.61 million, a price-to-earnings ratio of -1.64 and a beta of 1.72. The stock's 50-day moving average price is $2.83 and its 200 day moving average price is $3.30.</p>
<div class="lb-trans"><p>在周二的交易中，纳斯达克 HCAT 股价下跌 0.03 美元，达到 2.61 美元。493,261 股股票易手，交易量低于其平均交易量 704,965 股。Health Catalyst, Inc.的 52 周最低价为 2.02 美元，52 周最高价为 8.52 美元。该公司的速动比率为 1.88，流动比率为 1.88，债务与股本比率为 0.46。该公司的市值为 1.8461 亿美元，市盈率为-1.64，贝塔值为 1.72。该股票的 50 日移动平均价格为 2.83 美元，200 日移动平均价格为 3.30 美元。</p>
</div><p>Health Catalyst (NASDAQ:HCAT - Get Free Report) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.05 by $0.01. Health Catalyst had a negative return on equity of 6.67% and a negative net margin of 34.05%.The business had revenue of $76.32 million for the quarter, compared to the consensus estimate of $75.05 million. Analysts predict that Health Catalyst, Inc. will post -0.33 EPS for the current year.</p>
<div class="lb-trans"><p>Health Catalyst（纳斯达克代码：HCAT - 获取免费报告）最近在 11 月 10 日星期一发布了季度财报。该公司报告本季度每股收益为 0.06 美元，超出市场共识预期的 0.05 美元，超出 0.01 美元。Health Catalyst 的股本回报率为-6.67%，净利润率为-34.05%。该公司本季度的收入为 7632 万美元，超过市场共识预期的 7505 万美元。分析师预测 Health Catalyst, Inc.本年度将发布-0.33 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>The 10 Top-Rated Stocks by Wall Street Analysts in June 2021</li>
</ul>
<div class="lb-trans"><ul>
<li>2021 年 6 月华尔街分析师推荐的 10 只顶级股票</li>
</ul>
</div><p>HCAT has been the subject of a number of research reports. Piper Sandler cut Health Catalyst from an &#34;overweight&#34; rating to a &#34;neutral&#34; rating and lowered their target price for the stock from $8.00 to $4.00 in a research note on Wednesday, August 27th. UBS Group reiterated an &#34;outperform&#34; rating on shares of Health Catalyst in a report on Tuesday, November 11th. Citigroup lowered their price objective on shares of Health Catalyst from $3.50 to $3.25 and set a &#34;neutral&#34; rating for the company in a research report on Tuesday, November 11th. Evercore ISI dropped their price objective on shares of Health Catalyst from $4.00 to $3.00 and set an &#34;in-line&#34; rating on the stock in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group reduced their target price on shares of Health Catalyst from $9.00 to $5.00 and set a &#34;buy&#34; rating for the company in a research note on Friday, August 29th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Hold&#34; and an average target price of $4.36.</p>
<div class="lb-trans"><p>HCAT 已成为多份研究报告的主题。Piper Sandler 在 8 月 27 日星期三的研究报告中将 Health Catalyst 的评级从 “超配” 下调至 “中性”，并将其目标价从 8.00 美元下调至 4.00 美元。瑞银集团在 11 月 11 日星期二的报告中重申了对 Health Catalyst 股票的 “跑赢大盘” 评级。花旗集团在 11 月 11 日星期二的研究报告中将 Health Catalyst 股票的目标价从 3.50 美元下调至 3.25 美元，并对该公司设定了 “中性” 评级。Evercore ISI 在 10 月 8 日星期三的报告中将 Health Catalyst 股票的目标价从 4.00 美元下调至 3.00 美元，并对该股票设定了 “持平” 评级。最后，加拿大皇家银行在 8 月 29 日星期五的研究报告中将 Health Catalyst 股票的目标价从 9.00 美元下调至 5.00 美元，并对该公司设定了 “买入” 评级。五家股票研究分析师对该股票给予了买入评级，八家给予了持有评级，一家给予了卖出评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价为 4.36 美元。</p>
</div><p><strong>Get Our Latest Analysis on Health Catalyst</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Health Catalyst 的最新分析</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds have recently bought and sold shares of HCAT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Health Catalyst by 7.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company's stock worth $163,000 after purchasing an additional 2,624 shares in the last quarter. Campbell &amp; CO Investment Adviser LLC grew its stake in shares of Health Catalyst by 9.7% in the second quarter. Campbell &amp; CO Investment Adviser LLC now owns 43,051 shares of the company's stock valued at $162,000 after buying an additional 3,808 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Health Catalyst by 19.6% during the second quarter. The Manufacturers Life Insurance Company now owns 26,491 shares of the company's stock worth $100,000 after buying an additional 4,341 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in Health Catalyst by 71.7% during the third quarter. BNP Paribas Financial Markets now owns 16,355 shares of the company's stock worth $47,000 after buying an additional 6,832 shares during the last quarter. Finally, Probity Advisors Inc. raised its position in Health Catalyst by 20.5% during the third quarter. Probity Advisors Inc. now owns 45,161 shares of the company's stock worth $129,000 after acquiring an additional 7,671 shares in the last quarter. 85.00% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>最近，一些对冲基金买入和卖出了 HCAT 的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Health Catalyst 的股份增加了 7.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前拥有 36,047 股公司股票，价值 163,000 美元，此前在上个季度购买了 2,624 股。Campbell &amp; CO Investment Adviser LLC 在第二季度将其在 Health Catalyst 的股份增加了 9.7%。Campbell &amp; CO Investment Adviser LLC 目前拥有 43,051 股公司股票，价值 162,000 美元，此前在上个季度购买了 3,808 股。制造商人寿保险公司在第二季度将其在 Health Catalyst 的持股增加了 19.6%。制造商人寿保险公司目前拥有 26,491 股公司股票，价值 100,000 美元，此前在上个季度购买了 4,341 股。法国巴黎银行金融市场在第三季度将其在 Health Catalyst 的持股增加了 71.7%。法国巴黎银行金融市场目前拥有 16,355 股公司股票，价值 47,000 美元，此前在上个季度购买了 6,832 股。最后，Probity Advisors Inc.在第三季度将其在 Health Catalyst 的持股增加了 20.5%。Probity Advisors Inc.目前拥有 45,161 股公司股票，价值 129,000 美元，此前在上个季度购买了 7,671 股。85.00% 的股票目前由机构投资者持有。</p>
</div><h2>About Health Catalyst</h2>
<div class="lb-trans"><h2>关于 Health Catalyst</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.</p>
<div class="lb-trans"><p>Health Catalyst, Inc.为美国的医疗组织提供数据和分析技术及服务。它分为两个部门，技术和专业服务。该公司提供数据操作系统数据平台，为客户提供一个综合环境，以整合和组织来自不同软件系统的数据；以及分析应用程序，这是为数据平台构建的软件分析应用程序，用于分析客户在临床和质量、人口健康以及财务和运营用例方面面临的问题。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Health Catalyst</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li>
<li>Bank Stocks - Best Bank Stocks to Invest In</li>
<li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Health Catalyst 更好</li>
<li>什么是股票市场指数，如何使用它们？</li>
<li>消费者得到了煤炭，但圣诞老人给这两家零售商带来了巨大的收益</li>
<li>银行股票 - 最佳银行股票投资指南</li>
<li>10 倍收益？这三只机器人股票可能在 2035 年爆发</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>安海斯 - 布希收购 BeatBox 以吸引年轻饮酒者</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=HCAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Health Catalyst Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Health Catalyst 吗？</h2>
</div><p>Before you consider Health Catalyst, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Health Catalyst 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health Catalyst wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前购买……而 Health Catalyst 并不在名单上。</p>
</div><p>While Health Catalyst currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Health Catalyst 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Health Catalyst (NASDAQ:HCAT) 的一位董事出售了价值 128,151.99 美元的股票